The One Statistic to Forever Scare You Away From Drugs

Share this with your children.

National Journal
Brian Resnick
Add to Briefcase
See more stories about...
Brian Resnick
Feb. 7, 2014, 6:51 a.m.

Ac­cord­ing to a newly re­leased study from the Journ­al of Sub­stance Ab­use Treat­ment, hard drug users who use both heroin and co­caine have a mor­tal­ity rate that is 14.3 times high­er than the pop­u­la­tion at large. 

For users of co­caine alone, that rate is 5.1 times high­er. 

The res­ults come from a sur­vey of more than 20,000 drug users in Spain who were ad­mit­ted in­to treat­ment pro­grams over the span of 10 years (1997-2007). The re­search­ers fol­lowed up on the par­ti­cipants un­til 2008, ac­cu­mu­lat­ing “a total of 132,824 per­son-years of fol­low-up,” they wrote — a truly massive amount of data.

The au­thors sug­gest this is per­haps the largest sample of drug users ever stud­ied. 

Here are some of their grim find­ings.

  • “Heroin use was also the strongest in­de­pend­ent pre­dict­or of a high­er mor­tal­ity risk among all co­caine users.”
  • “Oth­er sig­nificant risk factors were daily co­caine use and hav­ing been pre­vi­ously ad­mit­ted to drug treat­ment.”
  • “Not hav­ing reg­u­lar em­ploy­ment and life­time drug in­jec­tion were im­port­ant in­de­pend­ent mor­tal­ity risk factors both among [co­caine-only users] and [co­caine and heroin users].”

Their find­ings also sug­gest that co­caine use is slightly more dan­ger­ous for wo­men than men, but they are not sure why. 

Though the num­bers are stark, the re­search­ers do ad­mit that their sample was lim­ited to people who have entered re­hab, which could mean the par­ti­cipants in their sample had a more ag­gress­ive drug habit than what would be rep­res­en­ted in a truly ran­dom sample. And also, dir­ect caus­a­tion can’t be in­ferred from a sur­vey. “This ex­cess mor­tal­ity can­not auto­mat­ic­ally be at­trib­uted to co­caine or heroin use, be­cause par­ti­cipants and the gen­er­al pop­u­la­tion may dif­fer in oth­er factors that were not as­sessed, such as men­tal dis­orders, per­son­al­ity factors, [and] so­cial con­di­tions,” they write.

But still, even if it serves as a high bound­ary of the risks of us­ing drugs, it’s a bound­ary you don’t want to ap­proach. After all, who would would want to even double their chance of dy­ing, let alone in­creas­ing it 14-fold.

What We're Following See More »
BOENTE WILL TAKE OVER AS G.C.
Rybicki Departs FBI
11 hours ago
THE LATEST

"FBI Director Chris Wray will change his chief of staff in the coming weeks, multiple sources told CNN Tuesday. James Rybicki, who served Wray's predecessor, James Comey, in the same role, will soon leave, the sources said. Zachary Harmon, a white-collar lawyer, will take on the role." Rybicki played a "role in crafting a statement that exonerated Hillary Clinton in her email server investigation." In related news, the Washington Post reports that "Dana Boente, the U.S. attorney in the Eastern District of Virginia who is acting head of the Justice Department’s national security division, has been selected to be the FBI’s next general counsel."

Source:
TRUMP TEAM HOPES TO ANSWER IN “HYBRID FORM”
Mueller Seeks to Interview Trump
12 hours ago
THE LATEST

"Special counsel Robert S. Mueller III is seeking to question President Trump in the coming weeks about his decisions to oust national security adviser Michael Flynn and FBI Director James B. Comey, according to two people familiar with his plans. ... The president’s legal team hopes to provide Trump’s testimony in a hybrid form — answering some questions in a face-to-face interview and others in a written statement."

Source:
SUSPECT CONTINUED INVOLVEMENT OF RUSSIAN BOTS
Feinstein, Schiff Call on Facebook, Twitter to Investigate “Release the Memo” Campaign
17 hours ago
THE LATEST
LAST WEEK
Mueller Interviewed Sessions
18 hours ago
THE LATEST
Source:
SHUTDOWN OFFICIALLY ENDS
Trump Signs Spending Bill
1 days ago
THE LATEST
×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login